Clinical Trials Directory

Trials / Completed

CompletedNCT03027349

Serum Calcium to Phosphorous Ratio (Ca/P) as a Simple, Inexpensive Screening Tool in the Diagnosis of Primary Hyperparathyroidism

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Azienda USL Modena · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Background: Primary hyperparathyroidism (PHPT) is often overlooked and underdiagnosed. At present the diagnosis of PHPT remains challenging and is based on serum calcium (Ca) and PTH. As serum Ca and phosphorous (P) are inversely related in PHPT, the Ca/P ratio might be considered a good candidate tool in the diagnosis of PHPT. AIM: The aim of this study is to investigate the diagnostic value of the Ca/P ratio in the diagnosis of PHPT. Study design: Retrospective, observational, cross-sectional, case-control clinical trial will be carried out. Biochemical measurements will include PTH, Vitamin D, serum Ca, P, albumin, and creatinine.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention are provided

Timeline

Start date
2011-01-01
Primary completion
2017-02-01
Completion
2017-02-01
First posted
2017-01-23
Last updated
2017-02-15

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03027349. Inclusion in this directory is not an endorsement.